These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1450701)

  • 21. A randomized, controlled trial of interferon alfa-2b alone and with simultaneous prednisone for the treatment of chronic hepatitis B. French Multicenter Group.
    Zarski JP; Causse X; Cohard M; Cougnard J; Trepo C
    J Hepatol; 1994 Jun; 20(6):735-41. PubMed ID: 7930473
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospective randomized controlled trial of sequential treatment with corticoids and alpha-interferon versus treatment with interferon alone in patients with chronic active hepatitis B.
    Niederau C; Heintges T; Niederau M; Stremmel W; Strohmeyer G
    Eur J Med; 1992 Nov; 1(7):396-402. PubMed ID: 1341478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment of chronic hepatitis B with interferon alfa-2b (Intron A)].
    Cianciara J; Laskus T; Hryniewicz H; Jabłońska J; Loch T
    Przegl Epidemiol; 1991; 45(4):315-20. PubMed ID: 1841409
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clearance of chronic hepatitis B virus infection in young children after alpha interferon treatment.
    Narkewicz MR; Smith D; Silverman A; Vierling J; Sokol RJ
    J Pediatr; 1995 Nov; 127(5):815-8. PubMed ID: 7472844
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interferon-induced chronic active hepatitis?
    Silva MO; Reddy KR; Jeffers LJ; Hill M; Schiff ER
    Gastroenterology; 1991 Sep; 101(3):840-2. PubMed ID: 1860646
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B.
    Niederau C; Heintges T; Lange S; Goldmann G; Niederau CM; Mohr L; Häussinger D
    N Engl J Med; 1996 May; 334(22):1422-7. PubMed ID: 8618580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protection from clinical varicella disease during interferon alpha-2a therapy for chronic active hepatitis B infection.
    Curtiss D; Kaufman S; Harrison CJ
    Pediatr Infect Dis J; 1997 Jul; 16(7):720-2. PubMed ID: 9239783
    [No Abstract]   [Full Text] [Related]  

  • 28. Simultaneous steroids/interferon therapy in chronic hepatitis B.
    Causse X; Godinot H; Chevallier M; Chossegros P; Zoulim F; Zarski JP; Meschiewitz C; Albrecht J; Trépo C
    J Hepatol; 1993 Jan; 17(1):128-9. PubMed ID: 8445212
    [No Abstract]   [Full Text] [Related]  

  • 29. A randomized, controlled trial of recombinant alpha-interferon therapy for chronic hepatitis B.
    Di Bisceglie AM; Fong TL; Fried MW; Swain MG; Baker B; Korenman J; Bergasa NV; Waggoner JG; Park Y; Hoofnagle JH
    Am J Gastroenterol; 1993 Nov; 88(11):1887-92. PubMed ID: 8237937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is there an alternative to alpha-interferon in chronic hepatitis B?
    de Moura MC; Velosa J; Pinto HC
    J Hepatol; 1991; 13 Suppl 1():S12-6. PubMed ID: 1960375
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recombinant interferon alfa-2b following prednisone withdrawal in the treatment of chronic type B hepatitis.
    Perez V; Tanno H; Villamil F; Fay O
    J Hepatol; 1990; 11 Suppl 1():S113-7. PubMed ID: 2079567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interferon alfa-2b treatment of HBeAg negative/serum HBV DNA positive chronic active hepatitis type B.
    Hadziyannis S; Bramou T; Makris A; Moussoulis G; Zignego L; Papaioannou C
    J Hepatol; 1990; 11 Suppl 1():S133-6. PubMed ID: 2079571
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interferon treatment of chronic active hepatitis B: effect of a six month treatment regimen.
    Raptopoulou M; Orphanou H; Vrettou H; Akribiadis E; Chadzikonstantinou L; Goulis G
    Gut; 1993; 34(2 Suppl):S102-3. PubMed ID: 8314469
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PreS1 antigen/antibody patterns following interferon therapy in acute and chronic hepatitis B.
    Petit MA; Zoulim F; Berthillon P; Capel F; Li J; Dauguet C; Ferrari C; Trépo C
    J Hepatol; 1994 Jan; 20(1):47-56. PubMed ID: 8201222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial.
    Bazinet M; Pântea V; Cebotarescu V; Cojuhari L; Jimbei P; Albrecht J; Schmid P; Le Gal F; Gordien E; Krawczyk A; Mijočević H; Karimzadeh H; Roggendorf M; Vaillant A
    Lancet Gastroenterol Hepatol; 2017 Dec; 2(12):877-889. PubMed ID: 28964701
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative study of three doses of interferon-alpha 2a in chronic active hepatitis B. The International Hepatitis Trial Group.
    Thomas HC; Lok AS; Carreño V; Farrell G; Tanno H; Perez V; Dusheiko GM; Cooksley G; Ryff JC
    J Viral Hepat; 1994; 1(2):139-48. PubMed ID: 8790569
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alpha-interferon combined with immunomodulation in the treatment of chronic hepatitis B.
    Peters M
    J Gastroenterol Hepatol; 1991; 6 Suppl 1():13-4. PubMed ID: 1751797
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Zidovudine plus interferon alfa-2b treatment in patients with HIV and chronic active viral hepatitis.
    Visco G; Alba L; Grisetti S; Guarascio P; Narciso P; Sette P; Struglia C; Tossini G; Tozzi V
    Gut; 1993; 34(2 Suppl):S107-8. PubMed ID: 8314472
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low dose alpha interferon treatment in chronic hepatitis B virus infection.
    Müller R; Baumgarten R; Markus R; Schulz M; Wittenberg H; Hintsche-Kilger B; Fengler JD; von Wussow P; Meisel H; Klein H
    Gut; 1993; 34(2 Suppl):S97-8. PubMed ID: 8314499
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prednisone withdrawal followed by recombinant alpha interferon in the treatment of chronic type B hepatitis. A randomized, controlled trial.
    Perrillo RP; Regenstein FG; Peters MG; DeSchryver-Kecskemeti K; Bodicky CJ; Campbell CR; Kuhns MC
    Ann Intern Med; 1988 Jul; 109(2):95-100. PubMed ID: 3289433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.